SILO Stock: Silo Pharma Jumps Into Rheumatoid Arthritis

Silo Pharma SILO Stock News

Silo Pharma, Inc. (OTCQB: SILO) is headed up in the market this morning, and for good reason. The company announced that it entered into an exclusive option agreement surrounding patented homing peptides for the potential treatment of Rheumatoid Arthritis.  Here’s what’s happening: Skip to What You Want to Read Silo Pharma Enters Option Agreement Management … Read more

SNGX Stock: Soligenix Rockets on COVID-19 News

Soligenix SNGX Stock News

Soligenix, Inc. (NASDAQ: SNGX) is running up in the premarket hours this morning, and for good reason. The company announced positive preclinical data from a COVID-19 vaccine program.  Here’s what’s happening: Skip to What You Want to Read Soligenix Announces COVID-19 Vaccine News Management Commentary What Analysts Think About SNGX Stock Risks to Consider Before … Read more

OVID Stock: Ovid Therapeutics Climbs On Takeda Agreement

Ovid Therapeutics OVID Stock News

Ovid Therapeutics Inc (NASDAQ: OVID) is screaming for the top in the market this morning after the company announced that Takeda Pharmaceutical Company has acquired the rights to soticlestat. Here’s what’s going on: Skip to What You Want to Read Ovid Therapeutics Announces Exclusive Agreement Management Commentary Risks to Consider Before Buying OVID Stock Final … Read more

KMPH Stock: FDA Approval Sends KemPharm Rocketing

KemPharm KMPH Stock News

KemPharm Inc (NASDAQ: KMPH) is rocketing in the market this morning after announcing that the FDA has approved a new drug. The company’s treatment for attention deficit hyperactivity disorder, or ADHD, will be hitting the market soon.  Here’s what’s going on: Skip to What You Want to Read KemPharm Announces FDA Approval Management Commentary A … Read more

CFMS Stock: Austrialian Approval Is Exciting News

ConforMIS CFMS Stock News

ConforMIS Inc (NASDAQ: CFMS) is headed up in the market this morning after announcing that it has received Australian regulatory approval for a medical device. Here’s what’s going on: Skip to What You Want to Read ConforMIS Announces Regulatory Approval Management Commentary What Analysts Think About CFMS Stock Risks to Consider Before Buying CFMS Stock … Read more

NNVC Stock: NanoViricides Rockets on COVID-19 News

NanoViricides NNVC Stock News

NanoViricides Inc (NYSEAMERICAN: NNVC) is flying in the market this morning, and for good reason. The company announced strong pan-coronavirus effectiveness of two COVID-19 clinical drug candidates. Here’s what’s going on: Skip to What You Want to Read NanoViricides Announces Positive COVID-19 News A Short Squeeze In Play Risks to Consider Before Buying NNVC Stock … Read more